Vernakalant (RSD1235)
目录号: A11603
Vernakalant 是一种研究中的混合型离子通道阻断剂,能够在人体中以 2 到 5 mg/kg 的剂量终止急性心房颤动(AF),并可能比现有药物更具心房选择性。
Discription | Vernakalant is an investigational mixed ion channel blocker that can terminate acute atrial fibrillation (AF) in humans at 2 to 5 mg/kg and may be more atrial-selective than available agents. |
---|
目录号 | A11603 |
---|---|
分子式 | C20H31NO4 |
分子量 | 349.46 |
CAS号 | 794466-70-9 |
SMILES | COC1=C(OC)C=C(CCOC2CCCCC2N3CCC(O)C3)C=C1 |
其他名称 | RSD1235, RSD 1235, RSD-1235 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2